GlobalFoundries Inc. Ordinary Shares vs ImmunityBio Inc. Common Stock — how do they compare? GlobalFoundries Inc. Ordinary Shares trades at $47.85 (market cap $27.51B), while ImmunityBio Inc. Common Stock trades at $10.46 (market cap $10.51B). The key difference: GlobalFoundries Inc. Ordinary Shares is far larger — about 2.6× ImmunityBio Inc. Common Stock's market cap, and GlobalFoundries Inc. Ordinary Shares pays a 0.97% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold GlobalFoundries Inc. Ordinary Shares for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| GFS | IBRX | |
|---|---|---|
Market Cap | $27.51B | $10.51B |
Volume | 10,416,572 | 10,445,785 |
Sector | Technology | Health |
52-Week High | $89.96 | $11.55 |
52-Week Low | $32.24 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $26.80B | $10.97B |
Dividend Yield | 0.97% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
GlobalFoundries is a semiconductor foundry that manufactures chips for other companies. Its technologies serve automotive, communications, industrial, and consumer markets.
Read more on GFS →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →